Data / Form D filings / DepYmed Inc.
DepYmed Inc.: Form D filings
DepYmed Inc., a pharmaceuticals company in Farmingdale, NY, filed 6 Form D notices with the SEC between 2021 and 2025. The latest, on April 25, 2025, reports $250,000 sold of a $250,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 BIOSCIENCE PARK DRIVE, Farmingdale, NY, 11735
- Phone
- (516) 662-8749
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1851177
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 25, 2025 | New notice | $250,000 | $250,000 | 1 | Apr 9, 2025 | sec.gov | |
| Feb 11, 2025 | New notice | $250,000 | $250,000 | 1 | Jan 29, 2025 | sec.gov | |
| Aug 16, 2024 | New notice | $600,000 | $600,000 | 2 | Aug 12, 2024 | sec.gov | |
| Mar 12, 2024 | New notice | $500,000 | $500,000 | 2 | Mar 6, 2024 | sec.gov | |
| May 4, 2023 | New notice | $2,000,000 | $2,000,000 | 2 | Mar 27, 2023 | sec.gov | |
| Apr 7, 2021 | New notice | $15,000,000 | $5,550,000 | $9,450,000 | 3 | Apr 1, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shankar G. Hariharan | Director | |
| Leo G. Guthart | Director | |
| Steve G. Winick | Director | |
| Peter G. Young | Director | |
| Andreas G. Grill | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Apr 21, 2025 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what DepYmed Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.